CancerNetwork Members: Login | Register
Become a fan on Facebook  Add us on Google Plus Follow us on Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

 
NEWS
Non-Small Cell Lung Cancer
emedicine.medscape.com - 3/22/13
Reflux Diseases
topics.searchmedica.com - 3/20/13
HIV Disease
emedicine.medscape.com - 3/19/13
 
PATIENT RESOURCES
FGFR1
ghr.nlm.nih.gov - 8/12/12
Cartilage-hair hypoplasia
ghr.nlm.nih.gov - 8/12/12
Search Results
ghr.nlm.nih.gov - 8/12/12

 

Order Your Copy!
(2010, 13th Edition)

 


 

Please allow 3 – 4 weeks to ship
 
PRACTICE GUIDELINES
National Guideline Clearinghouse | Staging laparoscopy for esophageal tumors. In: Diagnostic laparoscopy guidelines.
www.guidelines.gov -
National Guideline Clearinghouse | Role of EUS.
www.guidelines.gov -
National Guideline Clearinghouse | Role of esophageal stents in benign and malignant diseases.
www.guidelines.gov -

Esophageal Cancer
 
ESOPHAGEAL CANCER REVIEW ARTICLES

Multimodality Therapy for Esophageal Cancer
November 8, 2010

Recent developments in the epidemiology, staging, and treatment of esophageal and gastroesophageal junction cancers have led to significant changes in management.
• Targeted Therapy: an Evolving Concept in Esophageal Adenocarcinoma
• Preoperative Therapy in Esophageal Cancer: Controversy and Consensus

 
MORE FEATURES
March 8, 2013
Esophageal Cancer
Although still relatively uncommon in Western countries, esophageal cancer is fatal in the vast majority of cases. In the United States, an estimated... More »
February 11, 2013
Some Reassurance About Proton Pump Inhibitors and Risk of Osteoporotic Fractures
Despite limitations, this study lends some reassurance that risk of osteoporosis is not likely to overshadow the benefit of proton pump inhibitors in... More »
January 25, 2013
ASCO GI: Docetaxel for Advanced Esophagogastric Adenocarcinoma Improves Survival in Second-Line Setting
Adding the chemotherapy docetaxel to active symptom control in advanced esophagogastric adenocarcinoma improves survival of patients. These are the... More »
March 3, 2011
MUNICON-II: Early FDG-PET Scan Predicts Esophageal Ca Response to Therapy
Esophageal cancer generally has a poor prognosis; while preoperative chemotherapy is recommended, tumors often do not respond to treatment. More »
November 8, 2010
Targeted Therapy: an Evolving Concept in Esophageal Adenocarcinoma
Esophageal adenocarcinoma (EAC) affects approximately 11,000 persons per year in the United States, is increasing in incidence, and is associated with... More »
November 8, 2010
Preoperative Therapy in Esophageal Cancer: Controversy and Consensus
Dr. Krasna has written an overview of multimodality therapy in esophageal cancer, with a particular focus on aspects related to staging and surgical... More »
November 8, 2010
Multimodality Therapy for Esophageal Cancer
Recent developments in the epidemiology, staging, and treatment of esophageal and gastroesophageal junction cancers have led to significant changes in... More »
September 2, 2010
Oral Bisphosphonates Not Linked to Esophageal Cancer Risk
Esophagitis is a known adverse effect of bisphosphonate use and reflux esophagitis is an established risk factor for esophageal cancer through the... More »
June 7, 2010
Progress Reported in Advanced Esophageal Cancer
Meeting podcast: Listen to nationally regarded GI cancer specialist and clinical researcher, Peter C. Enzinger, MD, Assistant Professor of Medicine,... More »
March 9, 2010
Cancer Management Chapter 10: Gastric cancer
Gastric cancer is more common than esophageal cancer in Western countries but is less fatal. More than 21,130 new cases of gastric cancer will be... More »
Showing 1 - 10 of 63 results.
Page of 7
First Previous Last
 
CLINICAL TRIALS
Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)
www.clinicaltrials.gov -
Sorafenib Tosylate in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer
www.clinicaltrials.gov -
Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
www.clinicaltrials.gov -
Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer
www.clinicaltrials.gov -
S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
www.clinicaltrials.gov -


 
TOPIC INDEX

Cancer Types

  

Supportive Care

More Topics


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 
 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.